19.09.2019 • NewsElaine BurridgeNouryon

Nouryon and Van Remmen Link on Water Treatment

Nouryon and Van Remmen Link on Water Treatment
Nouryon and Van Remmen Link on Water Treatment

Nouryon has partnered with Van Remmen UV Technology, a Dutch water treatment company, to develop a novel method to address the growing problem of pharmaceutical micropollutants in waste water.

Pharmaceuticals are designed not to be broken down by the body, meaning that they end up in wastewater treatment plants, which often cannot remove the often complex and persistent molecules.

Van Remmen said its Advanox advanced oxidation process in combination with Nouryon’s MicrOx hydrogen peroxide technology can offer a solution. Inside an Advanox reactor, UV light splits the hydrogen peroxide molecules into highly reactive hydroxyl radicals, which in turn break down the drugs.

“Growing global pharmaceutical use is creating a significant pollution problem for urban waste water treatment systems,” said Niek Stapel, managing director pulp and performance chemicals at Nouryon. “With this advanced water treatment concept, customers in the water treatment market will have access to two proven technologies that together enable measurement, monitoring and means to control micropollutants in waste water streams.”

The combined process is being tested in a sewage treatment plant in Växjö, Sweden, where a pilot plant was installed at the end of July. Pilot trials started on Aug. 6 for a month and the results will be compiled and sent to both the Swedish Environmental Research Institute and the Swedish Environmental Protection Agency where it will be compared to other technologies for advanced water treatment and pharmaceutical removal.

Nouryon, which is supplying the hydrogen peroxide for the project, said it expects the combined process to remove more than 90% of pharmaceutical residues.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

most read

Photo
19.03.2025 • News

Arkema Launches Acrylic Acid Purification Project

Arkema has announced the launch of its Carat Project at its Carling site in France. This initiative aims to enhance the capabilities and sustainability of the facility, which specializes in producing acrylic monomers and superabsorbent polymers.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.